Position in PRCT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,364,873
+$1,966,043 QoQ
Shares Held
370,455
+44.8% QoQ
Ownership
0.647%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 254 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in PRCT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $3,192,742,950 across 81 Medical Devices names. PRCT ranks #22 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
9,681,750 | $413,217,085 | |
| 2 | ABT |
Abbott Laboratories
|
4,193,058 | $380,478,079 | |
| 3 | PODD |
Insulet Corp
|
2,455,135 | $373,794,300 | |
| 4 | STE |
STERIS plc
|
1,377,297 | $290,017,425 | |
| 5 | MDT |
Medtronic plc
|
3,299,627 | $258,129,817 | |
| 6 | DXCM |
Dexcom Inc
|
3,237,720 | $218,060,438 | |
| 7 | LIVN |
LivaNova PLC
|
2,356,191 | $193,749,582 | |
| 8 | HAE |
Haemonetics Corp
|
2,266,489 | $169,986,675 |
All Filings in PRCT
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,364,873 | 370,455 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $6,398,830 | 255,851 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,354,602 | 43,058 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,367,708 | 66,341 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $3,078,948 | 53,454 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $1,100,645 | 18,892 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,417,634 | 17,606 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $722,360 | 9,016 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $313,941 | 5,139 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||